Brown University
- SEC CIK
- 0001664741
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 5, 2026.SEC
- Positions
- 10
- −1 vs. Q1 2026
- Total value
- $95.3M
- −$6.55M (−6.4%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| STUBSTUBHUB HLDGS INC | CL A | 2,062,425 | $26.54M | 27.85% | 00.0% | Unchanged | View |
| OWLBLUE OWL CAPITAL INC | COM CL A | 2,569,816 | $22.49M | 23.60% | 00.0% | Unchanged | View |
| GLDSPDR GOLD SHARES | ETF | 39,500 | $14.55M | 15.27% | 00.0% | Unchanged | View |
| NVDANVIDIA CORPORATION COM | Stock | 53,000 | $10.6M | 11.13% | 00.0% | Unchanged | View |
| IBITISHARES BITCOIN TRUST ETF | ETF | 212,500 | $7.07M | 7.42% | 00.0% | Unchanged | View |
| CHYMCHIME FINL INC | COM SHS CL A | 204,625 | $4.19M | 4.40% | 00.0% | Unchanged | View |
| ATAI LIFE SCIENCES NVN0731H103 | SHS | 718,500 | $3.79M | 3.97% | 00.0% | Unchanged | – |
| CMPSCOMPASS PATHWAYS PLC | SPONSORED ADS | 214,200 | $3.03M | 3.18% | 00.0% | Unchanged | View |
| PROKPROKIDNEY CORP | COMMON STOCK | 1,000,000 | $2.04M | 2.14% | 00.0% | Unchanged | View |
| ACGLARCH CAP GROUP LTD ORD | Stock | 10,200 | $990.01K | 1.04% | +10,200 | New | View |
Options (1)
Put and call positions reported in the same filing. The value is that of the underlying shares, as reported on Form 13F.
| Security | Class | Puts | Calls |
|---|---|---|---|
| CBRSCEREBRAS SYSTEMS INC | COM CL A | $16.34M | – |
Sold out since Q1 2026 (2)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| OBDCBLUE OWL CAPITAL CORPORATION | COM | 1,524,863 | $16.86M | 16.56% |
| ISHARES TR464288257 | MSCI ACWI ETF | 35,400 | $4.9M | 4.81% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 10 | $95.3M | vs. Q1 2026 | SEC |
| Q1 2026 | May 1, 2026 | 11 | $101.85M | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 30, 2026 | 10 | $142.56M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 5, 2025 | 8 | $169.07M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 8, 2025 | 9 | $141.93M | vs. Q1 2025 | SEC |
| Q1 2025 | May 2, 2025 | 14 | $216.08M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 10, 2025 | 12 | $234.56M | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 8, 2024 | 10 | $247.06M | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 26, 2024 | 10 | $264.81M | vs. Q1 2024 | SEC |
| Q1 2024 | May 9, 2024 | 10 | $251.24M | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 8 | $276.89M | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 17, 2023 | 7 | $249.88M | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 1, 2023 | 6 | $269.13M | vs. Q1 2023 | SEC |
| Q1 2023 | May 10, 2023 | 7 | $261.42M | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 24, 2023 | 5 | $239.37M | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 3, 2022 | 6 | $246.62M | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 29, 2022 | 13 | $336.47M | vs. Q1 2022 | SEC |
| Q1 2022 | May 4, 2022 | 13 | $408.77M | vs. Q4 2021 | SEC |
| Q4 2021 | Jan 28, 2022 | 8 | $409.95M | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 25, 2021 | 8 | $737.71M | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 30, 2021 | 6 | $603.53M | vs. Q1 2021 | SEC |
| Q1 2021 | May 5, 2021 | 5 | $145.54M | – | SEC |